In addition, AKT inhibitor perifosine (Li et al, 2010, 2011) and mTOR inhibitors rapamycin (Johnsen et al, 2008), CCI‐779 (Johnsen et al, 2008), and Torin (Vaughan et al, 2016) were demonstrated to decrease proliferation in vitro and consequent tumor growth in vivo. The gene discussed is MTOR; the disease is neoplasm.